- Report
- August 2023
- 1300 Pages
Global
From €5975EUR$6,675USD£5,090GBP
€7967EUR$8,900USD£6,786GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €3290EUR$3,675USD£2,802GBP
€4386EUR$4,900USD£3,736GBP
- Report
- August 2023
- 300 Pages
Latin America
From €3290EUR$3,675USD£2,802GBP
€4386EUR$4,900USD£3,736GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €3290EUR$3,675USD£2,802GBP
€4386EUR$4,900USD£3,736GBP
- Report
- August 2023
- 300 Pages
Europe
From €3290EUR$3,675USD£2,802GBP
€4386EUR$4,900USD£3,736GBP
- Report
- August 2023
- 51 Pages
South Korea
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
India
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Mexico
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Australia
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Japan
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
United States
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Argentina
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Brazil
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Italy
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
China
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Spain
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Israel
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Colombia
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 51 Pages
South Africa
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more